PamGene is a Dutch biotechnology company that specializes in multiplex kinase activity profiling technology. The company provides contract research services and diagnostic assay services to support physicians and scientists in understanding diseases and improving patient treatment. PamGene's technology measures real-time cellular kinome activity, resulting in comprehensive and accurate data that can be used in clinical, translational, and pre-clinical settings to gain insights into discriminative drug responses, analyze and optimize kinase inhibitors, and discover novel biomarkers, targets, and pathways. The company's services include biomarker discovery, patient stratification, and therapy selection for oncological diseases, and its Diagnostic Assay Services facility is ISO13485 compliant.

Looking for Channel Partners in: